Shares of Molecular Devices rose 7.1 percent for the five-day trading period ended Tuesday, leading all firms in the BCW Index. All 15 companies in the Index gained ground for the week, though Bruker was the only other firm to eclipse a 5-percent rise for the period.
Overall, the Index rose 2.4 percent. In comparison, the Dow Jones Industrial Average and the Nasdaq each gained 1.6 percent for the same period. The Nasdaq Biotech Index was up 1.8 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.